- $7.90bn
- $9.12bn
- $3.78bn
Brief: Aptar Awarded Us FDA Contract To Study Opportunities For Low Global Warming Potential Propellants For Metered Dose Inhalers
U.S. RESEARCH ROUNDUP-Caterpillar, Intel, Yelp
Aptargroup Inc reports results for the quarter ended in September - Earnings Summary
Brief: Aptar Q3 Adjusted EPS USD 1.39 Vs. IBES Estimate USD 1.27
Aptargroup Inc expected to post earnings of $1.27 a share - Earnings Preview
Brief: Aptar Appoints Global Finance And Operations Veteran Sarah Glickman To Its Board Of Directors
U.S. RESEARCH ROUNDUP-Bath & Body Works, Eastman Chemical, New Relic
Aptargroup Inc reports results for the quarter ended in June - Earnings Summary
Brief: Aptar Reports Second Quarter 2023 Results
Brief: Aptar Q2 Adjusted EPS USD 1.23 Vs. IBES Estimate USD 1.14
Aptargroup Inc expected to post earnings of $1.14 a share - Earnings Preview
Brief: Aptar Announces Quarterly Dividend Increase Of 7.9%
U.S. RESEARCH ROUNDUP-Avalonbay Communities, B&G Foods, Essex Property Trust
Brief: Candace Matthews Elected Independent Chairperson Of Aptar’S Board Of Directors
Aptargroup Inc reports results for the quarter ended in March - Earnings Summary
Brief: Aptar Reports First Quarter 2023 Results
Brief: Aptar posts Q1 EPS of USD 0.82
Aptargroup Inc expected to post earnings of 90 cents a share - Earnings Preview
Brief: Aptar Surpasses Emissions Reduction Goals And Issues Updated Science-Based Targets In Line With 1.5°C Climate Ambition